Category: Inside BIO Industry Analysis
Patients Are at Core of Personalized Medicine Era
This week the Patient and Health Advocacy Summit concluded its sixth consecutive year, bringing hundreds …
Antimicrobial Resistance – 2017 BIO Investor Forum to Address Current Status
Alarm bells have been sounding for some time that deadly infections are developing resistance to …
"GMO Free Water"? Don't be Fooled by Misleading Labels
A recent article by Brandon McFadden in The Conversation dove into the food labeling craze, explaining how …
Op-Ed from Cancer Patient Warns: Don’t Sacrifice Cures Through Price Transparency
Deborah Goldberg’s op-ed to The Sacramento Bee recounts her three-year battle with colon cancer. She …
ICYMI: Jim Greenwood Outlines the Importance of Biotech Mosquitoes on World Mosquito Day
World Mosquito Day fell this past Sunday, providing an opportunity to highlight biotechnology’s contributions to …
It's a Wrap-BIO 2017 Delivers Again
Breaking all previous records, BIO 2017 hosted over 41,400 partnering meetings during this year’s event. …
BIO2017: Tuesday’s Exhibit Show Floor Finds
With over 1,800 exhibitors at BIO2017, there is truly something for everyone. From a …
Alnylam CEO John Maraganore Takes the Reins as BIO Chair
John Maraganore, CEO of Cambridge-based Alnylam Pharmaceuticals, begins his chairmanship of BIO this morning when …
Former UK Prime Minister David Cameron Zeroes in on Alzheimer’s Research at BIO 2017
Five years ago, during the height of his leadership, then-Prime Minister David Cameron of the …
Shotgun Start for BIO 2017
The 2017 BIO International Convention got off to a fast, fun and early start on …